Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Sildenafil
(SILDENAFIL POWDER,)Orphan drugCamber Pharmaceuticals, Inc.
12.1 Mechanism of Action Sildenafil is an inhibitor of cGMP specific PDE-5 in the smooth muscle of the pulmonary vasculature, where PDE-5 is responsib...
Browse all Idiopathic/heritable pulmonary arterial hypertension news →
Martin R Wilkins, MD
Imperial College London
📍 NEW HAVEN, CT
Theo Heller, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
📍 Bethesda, Maryland
Nicholas S Hill, MD
Tufts Medical Center
Evan Brittain, MD
Vanderbilt University Medical Center
📍 Nashville, Tennessee
Horst Olschewski, MD
Medical University of Graz
Fawaz Alenezi, MD
Duke Univeristy
View all Idiopathic/heritable pulmonary arterial hypertension specialists →